Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Change in Accured Expenses (2024 - 2025)

Historic Change in Accured Expenses for Kairos Pharma (KAPA) over the last 2 years, with Q2 2025 value amounting to -$129000.0.

  • Kairos Pharma's Change in Accured Expenses fell 63750.0% to -$129000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was -$246000.0, marking a year-over-year change of. This contributed to the annual value of $404000.0 for FY2024, which is 4766.84% down from last year.
  • Latest data reveals that Kairos Pharma reported Change in Accured Expenses of -$129000.0 as of Q2 2025, which was down 63750.0% from -$187000.0 recorded in Q1 2025.
  • In the past 5 years, Kairos Pharma's Change in Accured Expenses ranged from a high of $310000.0 in Q1 2024 and a low of -$191000.0 during Q3 2024